Norges Bank Takes $58.08 Million Position in ICU Medical, Inc. $ICUI

Norges Bank purchased a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) during the fourth quarter, HoldingsChannel reports. The firm purchased 407,115 shares of the medical instruments supplier’s stock, valued at approximately $58,083,000.

Other large investors have also recently added to or reduced their stakes in the company. Covestor Ltd boosted its holdings in ICU Medical by 22.1% in the 4th quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock valued at $99,000 after purchasing an additional 126 shares in the last quarter. Strs Ohio raised its stake in shares of ICU Medical by 60.0% during the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock worth $114,000 after buying an additional 300 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in shares of ICU Medical by 11.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after buying an additional 101 shares in the last quarter. Headlands Technologies LLC acquired a new stake in shares of ICU Medical in the 2nd quarter valued at approximately $177,000. Finally, Baker Avenue Asset Management LP acquired a new stake in shares of ICU Medical in the 4th quarter valued at approximately $212,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Price Performance

ICUI stock opened at $136.61 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.34 and a quick ratio of 1.17. The company’s 50 day simple moving average is $126.67 and its 200-day simple moving average is $138.63. ICU Medical, Inc. has a 12 month low of $107.00 and a 12 month high of $160.29. The firm has a market capitalization of $3.41 billion, a PE ratio of 73.84, a P/E/G ratio of 1.91 and a beta of 0.77.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.78 by $0.19. The firm had revenue of $525.77 million for the quarter, compared to analyst estimates of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.ICU Medical’s revenue was down 12.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.72 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Equities analysts expect that ICU Medical, Inc. will post 6.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ICUI. Piper Sandler dropped their price objective on ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Jefferies Financial Group raised ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Needham & Company LLC upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 target price on the stock in a research report on Wednesday, May 27th. Weiss Ratings raised shares of ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, May 11th. Finally, Wall Street Zen upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $168.00.

Insider Buying and Selling at ICU Medical

In related news, Director David C. Greenberg sold 2,424 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total transaction of $297,933.84. Following the sale, the director owned 7,960 shares of the company’s stock, valued at $978,363.60. This trade represents a 23.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total value of $303,623.76. Following the sale, the vice president owned 19,460 shares of the company’s stock, valued at approximately $2,414,596.80. This represents a 11.17% decrease in their position. The SEC filing for this sale provides additional information. 2.10% of the stock is owned by corporate insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.